These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 38750268)
1. Telemedicine for hepatitis C virus treatment in opioid treatment programmes. Hindson J Nat Rev Gastroenterol Hepatol; 2024 Jun; 21(6):376. PubMed ID: 38750268 [No Abstract] [Full Text] [Related]
2. Integrated Hepatitis C-Opioid Use Disorder Care Through Facilitated Telemedicine: A Randomized Trial. Talal AH; Markatou M; Liu A; Perumalswami PV; Dinani AM; Tobin JN; Brown LS JAMA; 2024 Apr; 331(16):1369-1378. PubMed ID: 38568601 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis C Virus Treatment Delivered via Telemedicine to Persons With Opioid Use Disorder. Talal AH; Dinani A; Brown LS JAMA Intern Med; 2022 Sep; 182(9):1011. PubMed ID: 35816336 [No Abstract] [Full Text] [Related]
4. Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C). Talal AH; Markatou M; Sofikitou EM; Brown LS; Perumalswami P; Dinani A; Tobin JN Contemp Clin Trials; 2022 Jan; 112():106632. PubMed ID: 34813962 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C Virus Reinfection Rate Among Persons Who Use Drugs and Are Maintained on Medication Treatment for Opioid Use Disorder. Springer SA Clin Infect Dis; 2020 Jun; 70(12):2703-2705. PubMed ID: 31346595 [No Abstract] [Full Text] [Related]
6. Facilitating engagement of persons with opioid use disorder in treatment for hepatitis C virus infection via telemedicine: Stories of onsite case managers. Talal AH; Jaanimägi U; Davis K; Bailey J; Bauer BM; Dharia A; George S; McLeod A; Morton K; Nugent A; Zeremski M; Dinani A; Des Jarlais DC; Perumalswami PV; Tobin JN; Dickerson SS J Subst Abuse Treat; 2021 Aug; 127():108421. PubMed ID: 34134875 [TBL] [Abstract][Full Text] [Related]
7. Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus Management in Opioid Use Disorder Patients on Methadone. Talal AH; Andrews P; Mcleod A; Chen Y; Sylvester C; Markatou M; Brown LS Clin Infect Dis; 2019 Jul; 69(2):323-331. PubMed ID: 30329042 [TBL] [Abstract][Full Text] [Related]
8. Patient Reaction to Telemedicine for Clinical Management of Hepatitis C Virus Integrated into an Opioid Treatment Program. Talal AH; McLeod A; Andrews P; Nieves-McGrath H; Chen Y; Reynolds A; Sylvester C; Dickerson SS; Markatou M; Brown LS Telemed J E Health; 2019 Sep; 25(9):791-801. PubMed ID: 30325701 [No Abstract] [Full Text] [Related]
9. Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis. Hajarizadeh B; Cunningham EB; Valerio H; Martinello M; Law M; Janjua NZ; Midgard H; Dalgard O; Dillon J; Hickman M; Bruneau J; Dore GJ; Grebely J J Hepatol; 2020 Apr; 72(4):643-657. PubMed ID: 31785345 [TBL] [Abstract][Full Text] [Related]
10. Scaling and Sustaining Facilitated Telemedicine to Expand Treatment Access Among Underserved Populations: A Qualitative Study. Ventuneac A; Dickerson SS; Dharia A; George SJ; Talal AH Telemed J E Health; 2023 Dec; 29(12):1862-1869. PubMed ID: 37252770 [No Abstract] [Full Text] [Related]
11. Facilitated telemedicine for hepatitis C virus: Addressing challenges for improving health and life for people with opioid use disorder. Talal AH; Jaanimägi U; Dharia A; Dickerson SS Health Expect; 2023 Dec; 26(6):2594-2607. PubMed ID: 37641398 [TBL] [Abstract][Full Text] [Related]
12. Comparison table: some drugs for maintenance treatment of opioid use disorder. Med Lett Drugs Ther; 2017 May; 59(1521):e96-e97. PubMed ID: 28609422 [No Abstract] [Full Text] [Related]
13. The impact of hepatitis C virus infection on methadone maintenance treatment. Novick DM Mt Sinai J Med; 2000; 67(5-6):437-43. PubMed ID: 11064495 [TBL] [Abstract][Full Text] [Related]
14. Drugs for opioid Use disorder. Med Lett Drugs Ther; 2017 Jun; 59(1522):89-95. PubMed ID: 28609420 [No Abstract] [Full Text] [Related]
15. Telemedicine's Role in Addressing the Opioid Epidemic. Yang YT; Weintraub E; Haffajee RL Mayo Clin Proc; 2018 Sep; 93(9):1177-1180. PubMed ID: 30097301 [No Abstract] [Full Text] [Related]
16. A rational approach to opioid use disorder in primary care. Tobin DG Cleve Clin J Med; 2017 May; 84(5):385-387. PubMed ID: 28530891 [No Abstract] [Full Text] [Related]
17. Direct-acting antiviral treatment of chronic HCV-infected patients on opioid substitution therapy: Still a concern in clinical practice? Christensen S; Buggisch P; Mauss S; Böker KHW; Schott E; Klinker H; Zimmermann T; Weber B; Reimer J; Serfert Y; Wedemeyer H Addiction; 2018 May; 113(5):868-882. PubMed ID: 29359361 [TBL] [Abstract][Full Text] [Related]
18. Direct Observed Therapy of Chronic Hepatitis C With Interferon-Free All-Oral Regimens at a Low-Threshold Drug Treatment Facility-a New Concept for Treatment of Patients With Borderline Compliance Receiving Opioid Substitution Therapy. Schìtz A; Moser S; Marchart K; Haltmayer H; Gschwantler M Am J Gastroenterol; 2016 Jun; 111(6):903-5. PubMed ID: 27249993 [No Abstract] [Full Text] [Related]
19. Characteristics and current clinical practices of opioid treatment programs in the United States. Jones CM; Byrd DJ; Clarke TJ; Campbell TB; Ohuoha C; McCance-Katz EF Drug Alcohol Depend; 2019 Dec; 205():107616. PubMed ID: 31678836 [TBL] [Abstract][Full Text] [Related]
20. The Shelby Clinic Medication-Assisted Treatment for Opioid Addiction. Penn CL J Ark Med Soc; 2016 Aug; 113(2):30-32. PubMed ID: 30047628 [No Abstract] [Full Text] [Related] [Next] [New Search]